NCT02586129
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +7 more
- Locations
-
- Seoul National Universitiy Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,310 public trials
330 recruiting studies
Lipid Metabolism Disorders trial results
NCT02463071
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
- Locations
-
- Research Site Aki-gun, Japan
- Research Site Chiba, Japan
- Research Site Chofu-shi, Japan
- Research Site Fukuoka, Japan
NCT00433147
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
- Locations
-
- San Francisco, California, United States
- Coral Springs, Florida, United States
- Decatur, Georgia, United States
- Iowa City, Iowa, United States
NCT02354976
- Conditions
- Digestive System Diseases, Dyslipidemias, Fatty Liver, +8 more
- Locations
-
- Research Site Gothenburg, Sweden
- Research Site Malmö, Sweden
- Research Site Stockholm, Sweden
- Research Site Uppsala, Sweden
NCT02480816
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified
NCT00941603
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
Not specified
Completed
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
NCT03680027
- Conditions
- Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified
NCT01420016
- Conditions
- Behavior, Cardiovascular Diseases, Cardiovascular Risk Factor, +13 more
- Locations
-
Not specified
Completed
(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol
NCT00526058
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
Completed
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
NCT03663465
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Mental Disorders, +4 more
- Locations
-
Not specified